why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat

Course: BCC and cSCC: Bridging Dermatologic and Oncologic Perspectives on Management Controversies

CME Credits: 1.00

Released: 2025-06-27

The management of patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) requires multi-modality treatment through multidisciplinary approaches, especially for more complex cases, including high-risk and recurrent disease. In addition, recent advances in immunotherapy can improve outcomes for patients with advanced BCC and advanced cSCC. Treatment options for patients with unresectable locally advanced or metastatic disease can be optimized when clinicians are up to date with the latest immunotherapies and guidelines. In the case of resectable disease, the use of immunotherapies can also be considered upon multidisciplinary consultation. In this three-module on-demand educational series, learn more about how to integrate evidence-based multi-modality therapies for BCC and cSCC, the efficacy and safety of immunotherapies to select the most appropriate therapy for each patient as well as the latest guidelines for BCC and cSCC management and adverse events associated with immunotherapy. An on-demand activity with expert commentary from Dr. James Grichnik, Dr. Lilia Correa, and Dr. Nikhil Khushalani will discuss clinical controversies, highlight modules 1-3 and review expert multidisciplinary approaches.


View Full Course